Skip to main content
HeartRhythm Case Reports logoLink to HeartRhythm Case Reports
. 2026 Mar 24;12(6):680–684. doi: 10.1016/j.hrcr.2026.03.015

Triple-balloon occlusion for targeted retrograde coronary venous ethanol ablation of left ventricular summit ventricular tachycardia

Mehmet Özgeyik 1,∗, Mehmet Semih Belpinar 1, Ramazan Anıl Eşki 2, Ibrahim Etem Dural 2, Basar Candemir 3
PMCID: PMC13270959  PMID: 42311516

Key Teaching Points.

  • •

    Ventricular arrhythmias originating from the left ventricular summit are frequently resistant to conventional endocardial radiofrequency ablation because of their epicardial location and complex intramural substrate.

  • •

    Retrograde coronary venous ethanol ablation represents an effective bailout strategy when previous endocardial and epicardial approaches fail.

  • •

    Intervenous collaterals may permit unintended ethanol spillover; multiballoon occlusion techniques can enhance ethanol confinement and improve lesion specificity.

  • •

    A triple-balloon technique may allow precise isolation of a predefined venous segment in complex coronary venous anatomy, facilitating targeted substrate modification while minimizing collateral myocardial injury.

Introduction

Radiofrequency (RF) catheter ablation is a guideline-recommended first-line therapy for drug-refractory ventricular arrhythmias (VAs).1,2 Despite its efficacy, procedural failure may occur owing to inadequate catheter–myocardial contact, anatomic barriers such as coronary arteries, prosthetic valves or phrenic nerve proximity, and deep intramural substrates inaccessible to conventional unipolar RF energy.3, 4, 5 To overcome these limitations, alternative strategies including bipolar RF ablation, needle ablation, stereotactic radioablation, half-normal saline irrigation, and ethanol ablation have been developed.6, 7, 8, 9, 10

Ethanol infusion induces myocardial necrosis through rapid cellular membrane disruption and protein denaturation. Both transarterial and transvenous approaches have been described for refractory ventricular substrates.11 Retrograde coronary venous ethanol ablation was developed to mitigate limitations of transarterial ethanol delivery such as coronary artery dissection, uncontrolled spillover, and rapid arteriovenous washout.

The left ventricular summit (LVS) represents the most superior epicardial portion of the basal left ventricular free wall, anatomically bounded by the left anterior descending and circumflex arteries. VAs originating from this region are frequently resistant to endocardial RF ablation owing to epicardial location and intramural depth.

However, intervenous collaterals may limit effective ethanol delivery by permitting distal leakage, thereby reducing lesion specificity and increasing the risk of nontarget myocardial injury. Double-balloon occlusion techniques have been described to improve localization.12 Here, we present a novel triple-balloon technique to enhance ethanol confinement in a patient with RF-refractory LVS ventricular tachycardia (VT).

Case report

A 66-year-old man with previous surgical aortic valve replacement and nonischemic cardiomyopathy presented with drug-refractory VT and recurrent implantable cardioverter-defibrillator shocks. Surface electrocardiography demonstrated ventricular ectopy consistent with LVS origin (Figure 1). Endocardial ablation via transseptal approach had previously been attempted. Despite high-power, long-duration lesions delivered both endocardially and within distal coronary venous branches, VT recurred. Epicardial access was unsuccessful owing to dense pericardial adhesions.

Figure 1.

Figure 1

Electrocardiogram of a ventricular premature beat consistent with left ventricular summit area.

The patient was scheduled for retrograde coronary venous ethanol ablation during a subsequent procedure. Using the CARTO 3-dimensional mapping system (Biosense Webster, Diamond Bar, CA) with a high-density Pentaray catheter introduced via transseptal access, the earliest endocardial activation was recorded at the anteromedial mitral annular region, adjacent to the presumed epicardial LVS origin. Diastolic activity was limited, suggesting an intramural or epicardial substrate.

The coronary venous system was cannulated using a bidirectional steerable sheath (Agilis, Abbott, Plymouth, MN). A JR4 guiding catheter was advanced to the junction of the great cardiac vein and anterior interventricular vein (AIV). Venography revealed a large annular vein supplying the basal septal region with an intercommunicating collateral draining into the AIV (Figure 2). To restrict ethanol delivery to the region opposite the presumed VT exit site, 2 guidewires were advanced into the distal annular vein and 1 into the collateral branch. A semicompliant over-the-wire balloon (2.5 × 15 mm) was positioned proximally at the great cardiac vein–AIV junction. A monorail balloon was positioned distally in the annular vein, and a second monorail balloon (1.5 × 12 mm) was placed within the collateral branch (Figure 3).

Figure 2.

Figure 2

Venous anatomy of distal coronary sinus (LAO 53° and caudal 26° projection). LAO = left anterior oblique.

Figure 3.

Figure 3

White arrows show the balloons’ positions (LAO 53° and caudal 26° projection) The catheter visualized in the fluoroscopic images represents the previously implanted CRT left ventricular pacing lead within the coronary venous system and not a mapping microcatheter. CRT = cardiac resynchronization therapy; LAO = left anterior oblique.

Dedicated venous activation mapping or pace mapping using a slim multipolar catheter or unipolar wire mapping was not performed owing to a lack of resources.

After confirming complete occlusion with contrast injection, ethanol was slowly administered through the proximal balloon (3 injections of 2 mL each). Progressive myocardial staining was observed after each injection (Figure 4). Postethanol electroanatomic mapping demonstrated increased bipolar scar in the targeted region (Figure 5), and VT was no longer inducible.

Figure 4.

Figure 4

Myocardial staining after ethanol infusion (LAO 53° and caudal 26° projection). LAO = left anterior oblique.

Figure 5.

Figure 5

Preablation and postablation voltage maps with projected mapping points displayed to illustrate local point density and spatial sampling distribution. Total point counts reflect all points acquired for the entire chamber geometry.

Peak high-sensitivity cardiac troponin I reached 21 ng/L (institutional upper reference limit 14 ng/L) on day 2 and subsequently declined. No clinical or electrocardiographic evidence of ischemia was observed. Postprocedural coronary angiography demonstrated no critical coronary artery stenosis, compression, or flow limitation. Repeated venography showed no venous dissection.

The patient was discharged uneventfully. At 6-month follow-up, implantable cardioverter-defibrillator interrogation revealed no recurrent VT episodes. 24-hour Holter monitoring demonstrated approximately 500 multiform ventricular extrasystoles. Importantly, these ectopic beats exhibited a superior axis morphology, whereas the preablation clinical VA had demonstrated an inferior axis, suggesting successful modification of the dominant LVS substrate rather than persistence of the original focus.

Discussion

Although RF ablation still remains the gold standard therapy for the VAs, it is far from perfection given that many scenarios such as LVS or intramural-epicardial substrates require bailout unconventional approaches such as bipolar ablation, needle ablation, half-saline ablation, and antegrade/retrograde ethanol administration into suitable branches. Ethanol ablation has emerged as a viable option recently. In a multicenter registry, acute success of retrograde ethanol was 98% and freedom from VAs at 1 year was 77%.13 However, there are still some significant caveats, such as inappropriate vascular anatomy to target leading to the inability to deliver ethanol to the desired area, insufficient myocardial damage owing to low dosage, or inadvertent damage to collateral tissue owing to downstream leakage through collaterals. In this case, we used a triple-balloon occlusion technique to prevent inadvertent damage to the anterior wall supplied by AIV. Double-balloon occlusion has been known to be used for large-bore venous posterolateral or middle cardiac vein branches14 but, to the best of our knowledge, this is the first case of triple-balloon retrograde ethanol administration for an LVS VA.

LVS arrhythmias are frequently challenging owing to deep intramural substrates.15 Intramural venous mapping poses a valuable window of opportunity for understanding the origin of LVS VAs. Unipolar wire recordings and slim multielectrode catheters can also be used to map coronary arteries or deep septal veins.16,17 Although this approach can enhance precision, owing to the lack of resources, targeting in this case was guided by detailed endocardial activation mapping and venographic-anatomic correlation.

Delivery of sufficient ethanol concentration over target site is another challenge. Although the exact number and volume of each ethanol application have not been standardized, most of the studies generally used 1 mL of ethanol and repeated the applications 3 times until myocardial staining with contrast was completed.14,18 Owing to the fact that our case was a recurrent one despite extensive ablation, we opted to use 3 × 2 mL of ethanol injections. Because ethanol is highly toxic to viable tissue, it is imperative that every caution should be taken to prevent inadvertent collateral damage. Sometimes, the target may be a large-bore vein supplying a broad area or one may find collaterals or interconnecting tributaries between the target and other major vein branches, precluding a single-balloon technique. These cases have been previously addressed with a double-balloon technique successfully.12,14 However, our case had both a large annular vein and a collateral, so we opted to use a triple balloon to restrict and intensify the alcohol effect to a predefined limited area.

At 6 months, the absence of recurrent VT and the morphologic shift from inferior to superior axis ventricular ectopy suggest durable modification of the dominant arrhythmogenic substrate. The residual multiform extrasystoles likely represent independent ectopic activity rather than persistence of the original LVS focus.

Conclusion

Retrograde venous ethanol ablation has been demonstrated to be a very effective option in selected challenging bailout VA cases resistant to extensive RF. A detailed understanding of the venous anatomy is crucial for safe and effective implementation of this bailout technique.

Disclosures

The authors have no conflicts of interest to disclose.

Acknowledgments

Funding Sources

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Data availability

The data supporting the findings of this case report are available from the corresponding author upon reasonable request. Owing to the nature of a single-patient case report and patient privacy considerations, the data are not publicly available.

Footnotes

Appendix

Supplementary data associated with this article can be found in the online version at https://doi.org/10.1016/j.hrcr.2026.03.015.

Appendix. Supplementary Data

Supplementary Video
Download video file (1.2MB, mp4)
Supplementary File
mmc2.docx (13.3KB, docx)

References

  • 1.Sapp J.L., Wells G.A., Parkash R., et al. Ventricular tachycardia ablation versus Escalation of antiarrhythmic Drugs. N Engl J Med. 2016;375:111–121. doi: 10.1056/NEJMoa1513614. [DOI] [PubMed] [Google Scholar]
  • 2.Zeppenfeld K., Tfelt-Hansen J., de Riva M., et al. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43:3997–4126. doi: 10.1093/eurheartj/ehac262. [DOI] [PubMed] [Google Scholar]
  • 3.Tavares L., Fuentes S., Lador A., et al. Venous anatomy of the left ventricular summit: therapeutic implications for ethanol infusion. Heart Rhythm. 2021;18:1557–1565. doi: 10.1016/j.hrthm.2021.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Lin C.Y., Chung F.P., Lin Y.J., et al. Radiofrequency catheter ablation of ventricular arrhythmias originating from the continuum between the aortic sinus of valsalva and the left ventricular summit: electrocardiographic characteristics and correlative anatomy. Heart Rhythm. 2016;13:111–121. doi: 10.1016/j.hrthm.2015.08.030. [DOI] [PubMed] [Google Scholar]
  • 5.Kumar S., Tedrow U.B., Stevenson W.G. Adjunctive interventional techniques when percutaneous catheter ablation for drug refractory ventricular arrhythmias fail: a contemporary review. Circ Arrhythm Electrophysiol. 2017;10 doi: 10.1161/CIRCEP.116.003676. [DOI] [PubMed] [Google Scholar]
  • 6.Valderrábano M., Fuentes Rojas S.C., Lador A., et al. Substrate ablation by multivein, multiballoon coronary venous ethanol for refractory ventricular tachycardia in structural heart disease. Circulation. 2022;146:1644–1656. doi: 10.1161/CIRCULATIONAHA.122.060882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Nguyen D.T., Tzou W.S., Brunnquell M., et al. Clinical and biophysical evaluation of variable bipolar configurations during radiofrequency ablation for treatment of ventricular arrhythmias. Heart Rhythm. 2016;13:2161–2171. doi: 10.1016/j.hrthm.2016.07.011. [DOI] [PubMed] [Google Scholar]
  • 8.Stevenson W.G., Tedrow U.B., Reddy V., et al. Infusion needle radiofrequency ablation for treatment of refractory ventricular arrhythmias. J Am Coll Cardiol. 2019;73:1413–1425. doi: 10.1016/j.jacc.2018.12.070. [DOI] [PubMed] [Google Scholar]
  • 9.Robinson C.G., Samson P.P., Moore K.M.S., et al. Phase I/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia. Circulation. 2019;139:313–321. doi: 10.1161/CIRCULATIONAHA.118.038261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Nguyen D.T., Tzou W.S., Sandhu A., et al. Prospective multicenter experience with cooled radiofrequency ablation using high impedance irrigant to target deep myocardial substrate refractory to standard ablation. JACC Clin Electrophysiol. 2018;4:1176–1185. doi: 10.1016/j.jacep.2018.06.021. [DOI] [PubMed] [Google Scholar]
  • 11.Schurmann P., Peñalver J., Valderrábano M. Ethanol for the treatment of cardiac arrhythmias. Curr Opin Cardiol. 2015;30:333–343. doi: 10.1097/HCO.0000000000000183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Da-Wariboko A., Lador A., Tavares L., et al. Double-balloon technique for retrograde venous ethanol ablation of ventricular arrhythmias in the absence of suitable intramural veins. Heart Rhythm. 2020;17:2126–2134. doi: 10.1016/j.hrthm.2020.05.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Tavares L., Lador A., Fuentes S., et al. Intramural venous ethanol infusion for refractory ventricular arrhythmias: outcomes of a multicenter experience. JACC Clin Electrophysiol. 2020;6:1420–1431. doi: 10.1016/j.jacep.2020.07.023. [DOI] [PubMed] [Google Scholar]
  • 14.Patel A., Nsahlai M., Flautt T., et al. Advanced techniques for ethanol ablation of left ventricular summit region arrhythmias. Circ Arrhythm Electrophysiol. 2022;15 doi: 10.1161/CIRCEP.122.011017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Yamada T., Maddox W.R., McElderry H.T., Doppalapudi H., Plumb V.J., Kay G.N. Radiofrequency catheter ablation of idiopathic ventricular arrhythmias originating from intramural foci in the left ventricular outflow tract: efficacy of sequential versus simultaneous unipolar catheter ablation. Circ Arrhythm Electrophysiol. 2015;8:344–352. doi: 10.1161/CIRCEP.114.002259. [DOI] [PubMed] [Google Scholar]
  • 16.Briceño D.F., Enriquez A., Liang J.J., et al. Septal coronary venous mapping to guide substrate characterization and ablation of intramural septal ventricular arrhythmia. JACC Clin Electrophysiol. 2019;5:789–800. doi: 10.1016/j.jacep.2019.04.011. [DOI] [PubMed] [Google Scholar]
  • 17.Komatsu Y., Nogami A., Shinoda Y., et al. Idiopathic ventricular arrhythmias originating from the vicinity of the communicating vein of cardiac venous systems at the left ventricular summit. Circ Arrhythm Electrophysiol. 2018;11 doi: 10.1161/CIRCEP.117.005386. [DOI] [PubMed] [Google Scholar]
  • 18.Fuentes S., Valderrábano M. Venous ethanol ablation approaches for radiofrequency-refractory cardiac arrhythmias. Curr Cardiol Rep. 2023;25:917–924. doi: 10.1007/s11886-023-01914-6. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Video
Download video file (1.2MB, mp4)
Supplementary File
mmc2.docx (13.3KB, docx)

Data Availability Statement

The data supporting the findings of this case report are available from the corresponding author upon reasonable request. Owing to the nature of a single-patient case report and patient privacy considerations, the data are not publicly available.


Articles from HeartRhythm Case Reports are provided here courtesy of Elsevier

RESOURCES